Bioventus, Inc. (BVS)
13.10
+0.41
(+3.23%)
USD |
NASDAQ |
Oct 09, 16:00
13.10
0.00 (0.00%)
After-Hours: 16:10
Bioventus Enterprise Value : 1.149B for Oct. 8, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 1.149B |
| October 07, 2026 | 1.154B |
| October 06, 2026 | 1.177B |
| October 05, 2026 | 1.206B |
| October 02, 2026 | 1.179B |
| October 01, 2026 | 1.201B |
| September 30, 2026 | 1.213B |
| September 29, 2026 | 1.238B |
| September 28, 2026 | 1.240B |
| September 25, 2026 | 1.225B |
| September 24, 2026 | 1.206B |
| September 23, 2026 | 1.212B |
| September 22, 2026 | 1.214B |
| September 21, 2026 | 1.191B |
| September 18, 2026 | 1.164B |
| September 17, 2026 | 1.145B |
| September 16, 2026 | 1.184B |
| September 15, 2026 | 1.170B |
| September 14, 2026 | 1.181B |
| September 11, 2026 | 1.169B |
| September 10, 2026 | 1.174B |
| September 09, 2026 | 1.213B |
| September 08, 2026 | 1.227B |
| September 04, 2026 | 1.243B |
| September 03, 2026 | 1.263B |
| Date | Value |
|---|---|
| September 02, 2026 | 1.264B |
| September 01, 2026 | 1.216B |
| August 31, 2026 | 1.214B |
| August 28, 2026 | 1.227B |
| August 27, 2026 | 1.224B |
| August 26, 2026 | 1.236B |
| August 25, 2026 | 1.244B |
| August 24, 2026 | 1.240B |
| August 21, 2026 | 1.264B |
| August 20, 2026 | 1.261B |
| August 19, 2026 | 1.285B |
| August 18, 2026 | 1.259B |
| August 17, 2026 | 1.230B |
| August 14, 2026 | 1.256B |
| August 13, 2026 | 1.231B |
| August 12, 2026 | 1.233B |
| August 11, 2026 | 1.228B |
| August 10, 2026 | 1.236B |
| August 07, 2026 | 1.247B |
| August 06, 2026 | 1.237B |
| August 05, 2026 | 1.324B |
| August 04, 2026 | 1.199B |
| August 03, 2026 | 1.202B |
| July 31, 2026 | 1.182B |
| July 30, 2026 | 1.182B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Accuray, Inc. | 175.31M |
| Micron Solutions, Inc. | -- |
| IDEXX Laboratories, Inc. | 41.37B |
| Neogen Corp. | 3.158B |
| Orthofix Medical, Inc. | 524.06M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 36.20M |
| Revenue (Quarterly) | 153.21M |
| Total Expenses (Quarterly) | 119.77M |
| EPS Diluted (Quarterly) | 0.4721 |
| Gross Profit Margin (Quarterly) | 68.29% |
| Profit Margin (Quarterly) | 23.63% |
| Earnings Yield | 5.92% |
| Operating Earnings Yield | 6.73% |
| Normalized Earnings Yield | 6.182 |